- Home
- APLT vs MED Comparison
APLT vs MED Comparison
Compare APLT & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- MED
- Stock Information
- Founded
- APLT 2016
- MED 1980
- Country
- APLT United States
- MED United States
- Employees
- APLT N/A
- MED N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- APLT Health Care
- MED Consumer Staples
- Exchange
- APLT Nasdaq
- MED Nasdaq
- Market Cap
- APLT 178.6M
- MED 150.7M
- IPO Year
- APLT 2019
- MED N/A
- Fundamental
- Price
- APLT $1.05
- MED $14.11
- Analyst Decision
- APLT Buy
- MED Hold
- Analyst Count
- APLT 5
- MED 1
- Target Price
- APLT $4.13
- MED $16.50
- AVG Volume (30 Days)
- APLT 11.8M
- MED 140.3K
- Earning Date
- APLT 11-06-2025
- MED 11-03-2025
- Dividend Yield
- APLT N/A
- MED N/A
- EPS Growth
- APLT N/A
- MED N/A
- EPS
- APLT N/A
- MED 0.33
- Revenue
- APLT $121,000.00
- MED $480,449,000.00
- Revenue This Year
- APLT N/A
- MED N/A
- Revenue Next Year
- APLT $5,931.24
- MED N/A
- P/E Ratio
- APLT N/A
- MED $42.34
- Revenue Growth
- APLT N/A
- MED N/A
- 52 Week Low
- APLT $0.30
- MED $11.57
- 52 Week High
- APLT $10.62
- MED $21.98
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- MED 47.85
- Support Level
- APLT $0.56
- MED $13.42
- Resistance Level
- APLT $1.32
- MED $14.06
- Average True Range (ATR)
- APLT 0.17
- MED 0.36
- MACD
- APLT 0.05
- MED -0.02
- Stochastic Oscillator
- APLT 73.60
- MED 29.32
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.